End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,383 KRW | -27.44% | -.--% | -.--% |
Business Summary
Number of employees: 16
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Others
40.2
%
| 7,343 | 33.8 % | 5,067 | 40.2 % | -30.99% |
5G
31.2
%
| 10,540 | 48.5 % | 3,936 | 31.2 % | -62.66% |
Pharmaceutical Development
28.7
%
| 2,712 | 12.5 % | 3,618 | 28.7 % | +33.40% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.9
%
| 20,895 | 96.2 % | 12,611 | 99.9 % | -39.65% |
United States
0.1
%
| 684 | 3.1 % | 10 | 0.1 % | -98.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dae-Woo Park
CEO | Chief Executive Officer | 55 | - |
Hyo-An Seong
AUD | Comptroller/Controller/Auditor | 57 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jae-Sang Jung
BRD | Director/Board Member | 51 | 19-01-03 |
Jae-Seok Im
BRD | Director/Board Member | 57 | 19-01-03 |
Dae-Woo Park
CEO | Chief Executive Officer | 55 | - |
Dae-Hye Kim
BRD | Director/Board Member | 42 | - |
Director/Board Member | 66 | - | |
Jeong-Hwan Yu
BRD | Director/Board Member | 57 | - |
Yo-Han Lee
BRD | Director/Board Member | 43 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,796,106 | 45,245,157 ( 96.69 %) | 0 | 96.69 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-.--% | 47.03M | |
-2.80% | 380B | |
+22.71% | 1.98B | |
-18.71% | 1.08B | |
-11.48% | 831M | |
+5.94% | 792M | |
+58.57% | 789M | |
+44.37% | 671M | |
-31.60% | 349M | |
-10.50% | 291M |
- Stock Market
- Equities
- A214870 Stock
- Company NewGLAB Pharma CO.,LTD